Heparin increases the infectivity of Human Papillomavirus Type 16 independent of cell surface proteoglycans and induces L1 epitope exposure

Cellular Microbiology

Volumn 15, Issue 11, 2013, Pages 1818-1836

  Cerqueira, Carla ^a   Liu, Yan ^b   Kühling, Lena ^a   Chai, Wengang ^b   Hafezi, Wali ^c   van Kuppevelt, Toin H ^d   Kühn, Joachim E ^c   Feizi, Ten ^b   Schelhaas, Mario ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEPARAN SULFATE; HEPARIN; KALININ; PROTEOGLYCAN;

ARTICLE; CELL SURFACE; CONCENTRATION (PARAMETERS); CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; RECEPTOR BINDING; VIRUS CAPSID;

HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; PAPILLOMAVIRIDAE;

CAPSID PROTEINS; CELL ADHESION MOLECULES; CELL LINE; EPITOPES; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PROTEIN BINDING; VIRUS ATTACHMENT;

EID: 84885419211     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12150     Document Type: Article

References (73)

1. Akhtar, J., and Shukla, D. (2009) Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J 276: 7228-7236.
2. Baker, T.S., Newcomb, W.W., Olson, N.H., Cowsert, L.M., Olson, C., and Brown, J.C. (1991) Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys J 60: 1445-1456.
3. Bienkowska-Haba, M., Patel, H.D., and Sapp, M. (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5: e1000524.
4. Bosch, F.X., and de Sanjose, S. (2003) Chapter 1: Human papillomavirus and cervical cancer - burden and assessment of causality. J Natl Cancer Inst Monogr 31: 3-13.
5. Broutian, T.R., Brendle, S.A., and Christensen, N.D. (2010) Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types. J Gen Virol 91: 531-540.
6. Buck, C.B., and Thompson, C.D. (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Chapter 26: Unit 26 21.
7. Buck, C.B., Pastrana, D.V., Lowy, D.R., and Schiller, J.T. (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78: 751-757.
8. Buck, C.B., Thompson, C.D., Pang, Y.Y., Lowy, D.R., and Schiller, J.T. (2005) Maturation of papillomavirus capsids. J Virol 79: 2839-2846.
9. Buck, C.B., Thompson, C.D., Roberts, J.N., Muller, M., Lowy, D.R., and Schiller, J.T. (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2: e69.
10. Buck, C.B., Cheng, N., Thompson, C.D., Lowy, D.R., Steven, A.C., Schiller, J.T., and Trus, B.L. (2008) Arrangement of L2 within the papillomavirus capsid. J Virol 82: 5190-5197.
11. Capila, I., and Linhardt, R.J. (2002) Heparin-protein interactions. Angew Chem Int Ed Engl 41: 391-412.
12. Chai, W., Luo, J., Lim, C.K., and Lawson, A.M. (1998) Characterization of heparin oligosaccharide mixtures as ammonium salts using electrospray mass spectrometry. Anal Chem 70: 2060-2066.
13. Chai, W., Beeson, J.G., Kogelberg, H., Brown, G.V., and Lawson, A.M. (2001) Inhibition of adhesion of Plasmodium falciparum-infected erythrocytes by structurally defined hyaluronic acid dodecasaccharides. Infect Immun 69: 420-425.
14. Chai, W., Beeson, J.G., and Lawson, A.M. (2002) The structural motif in chondroitin sulfate for adhesion of Plasmodium falciparum-infected erythrocytes comprises disaccharide units of 4-O-sulfated and non-sulfated N-acetylgalactosamine linked to glucuronic acid. J Biol Chem 277: 22438-22446.
15. Chai, W., Stoll, M.S., Galustian, C., Lawson, A.M., and Feizi, T. (2003) Neoglycolipid technology: deciphering information content of glycome. Methods Enzymol 362: 160-195.
16. Christensen, N.D., Kreider, J.W., Cladel, N.M., Patrick, S.D., and Welsh, P.A. (1990) Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J Virol 64: 5678-5681.
17. Christensen, N.D., Dillner, J., Eklund, C., Carter, J.J., Wipf, G.C., Reed, C.A., etal. (1996a) Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223: 174-184.
18. Christensen, N.D., Reed, C.A., Cladel, N.M., Hall, K., and Leiserowitz, G.S. (1996b) Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6. Virology 224: 477-486.
19. Christensen, N.D., Cladel, N.M., Reed, C.A., Budgeon, L.R., Embers, M.E., Skulsky, D.M., etal. (2001a) Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types. Virology 291: 324-334.
20. Christensen, N.D., Reed, C.A., Culp, T.D., Hermonat, P.L., Howett, M.K., Anderson, R.A., and Zaneveld, L.J. (2001b) Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob Agents Chemother 45: 3427-3432.
21. Combita, A.L., Touze, A., Bousarghin, L., Sizaret, P.Y., Munoz, N., and Coursaget, P. (2001) Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett 204: 183-188.
22. Culp, T.D., Budgeon, L.R., and Christensen, N.D. (2006a) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347: 147-159.
23. Culp, T.D., Budgeon, L.R., Marinkovich, M.P., Meneguzzi, G., and Christensen, N.D. (2006b) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80: 8940-8950.
24. Dasgupta, J., Bienkowska-Haba, M., Ortega, M.E., Patel, H.D., Bodevin, S., Spillmann, D., etal. (2011) Structural basis of oligosaccharide receptor recognition by human papillomavirus. J Biol Chem 286: 2617-2624.
25. Day, P.M., Thompson, C.D., Buck, C.B., Pang, Y.Y., Lowy, D.R., and Schiller, J.T. (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81: 8784-8792.
26. Day, P.M., Gambhira, R., Roden, R.B., Lowy, D.R., and Schiller, J.T. (2008a) Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol 82: 4638-4646.
27. Day, P.M., Lowy, D.R., and Schiller, J.T. (2008b) Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 82: 12565-12568.
28. Dierker, T., Dreier, R., Migone, M., Hamer, S., and Grobe, K. (2009) Heparan sulfate and transglutaminase activity are required for the formation of covalently cross-linked hedgehog oligomers. J Biol Chem 284: 32562-32571.
29. Dietrich, C.P., Nader, H.B., and Straus, A.H. (1983) Structural differences of heparan sulfates according to the tissue and species of origin. Biochem Biophys Res Commun 111: 865-871.
30. Evander, M., Frazer, I.H., Payne, E., Qi, Y.M., Hengst, K., and McMillan, N.A. (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71: 2449-2456.
31. Favre, M. (1975) Structural polypeptides of rabbit, bovine, and human papillomaviruses. J Virol 15: 1239-1247.
32. Florin, L., Sapp, M., and Spoden, G.A. (2012) Host-cell factors involved in papillomavirus entry. Med Microbiol Immunol 201: 437-448.
33. Gagnoux-Palacios, L., Vailly, J., Durand-Clement, M., Wagner, E., Ortonne, J.P., and Meneguzzi, G. (1996) Functional Re-expression of laminin-5 in laminin-gamma2-deficient human keratinocytes modifies cell morphology, motility, and adhesion. J Biol Chem 271: 18437-18444.
34. Giroglou, T., Florin, L., Schafer, F., Streeck, R.E., and Sapp, M. (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75: 1565-1570.
35. Hafezi, W., Lorentzen, E.U., Eing, B.R., Muller, M., King, N.J., Klupp, B., etal. (2012) Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog 8: e1002679.
36. Harvima, I.T., Lappalainen, K., Hirvonen, M.R., Matto, M., Kivinen, P.K., Hyttinen, M., etal. (2004) Heparin modulates the growth and adherence and augments the growth-inhibitory action of TNF-alpha on cultured human keratinocytes. J Cell Biochem 92: 372-386.
37. Humphries, D.E., and Silbert, J.E. (1988) Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem Biophys Res Commun 154: 365-371.
38. Jastrebova, N., Vanwildemeersch, M., Lindahl, U., and Spillmann, D. (2010) Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling. J Biol Chem 285: 26842-26851.
39. Jenniskens, G.J., Oosterhof, A., Brandwijk, R., Veerkamp, J.H., and van Kuppevelt, T.H. (2000) Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci 20: 4099-4111.
40. Johnson, K.M., Kines, R.C., Roberts, J.N., Lowy, D.R., Schiller, J.T., and Day, P.M. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83: 2067-2074.
41. Joyce, J.G., Tung, J.S., Przysiecki, C.T., Cook, J.C., Lehman, E.D., Sands, J.A., etal. (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274: 5810-5822.
42. Kines, R.C., Thompson, C.D., Lowy, D.R., Schiller, J.T., and Day, P.M. (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci USA 106: 20458-20463.
43. Klug, A., and Finch, J.T. (1965) Structure of viruses of the papilloma-polyoma type. I. Human wart virus. J Mol Biol 11: 403-423.
44. Knappe, M., Bodevin, S., Selinka, H.C., Spillmann, D., Streeck, R.E., Chen, X.S., etal. (2007) Surface-exposed amino acid residues of HPV16 L1 protein mediating interaction with cell surface heparan sulfate. J Biol Chem 282: 27913-27922.
45. Kurup, S., Wijnhoven, T.J., Jenniskens, G.J., Kimata, K., Habuchi, H., Li, J.P., etal. (2007) Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J Biol Chem 282: 21032-21042.
46. Levy, H.C., Bowman, V.D., Govindasamy, L., McKenna, R., Nash, K., Warrington, K., etal. (2009) Heparin binding induces conformational changes in Adeno-associated virus serotype 2. J Struct Biol 165: 146-156.
47. Liu, Y., Feizi, T., Campanero-Rhodes, M.A., Childs, R.A., Zhang, Y., Mulloy, B., etal. (2007) Neoglycolipid probes prepared via oxime ligation for microarray analysis of oligosaccharide-protein interactions. Chem Biol 14: 847-859.
48. Longworth, M.S., and Laimins, L.A. (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68: 362-372.
49. McLaughlin-Drubin, M.E., and Meyers, C. (2005) Propagation of infectious, high-risk HPV in organotypic 'raft' culture. Methods Mol Med 119: 171-186.
50. McMillan, N.A., Payne, E., Frazer, I.H., and Evander, M. (1999) Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology 261: 271-279.
51. Miquel, C., Gagnoux-Palacios, L., Durand-Clement, M., Marinkovich, P., Ortonne, J.P., and Meneguzzi, G. (1996) Establishment and characterization of cell line LSV5 that retains the altered adhesive properties of human junctional epidermolysis bullosa keratinocytes. Exp Cell Res 224: 279-290.
52. Modis, Y., Trus, B.L., and Harrison, S.C. (2002) Atomic model of the papillomavirus capsid. EMBO J 21: 4754-4762.
53. Palma, A.S., Feizi, T., Zhang, Y., Stoll, M.S., Lawson, A.M., Diaz-Rodriguez, E., etal. (2006) Ligands for the beta-glucan receptor, Dectin-1, assigned using 'designer' microarrays of oligosaccharide probes (neoglycolipids) generated from glucan polysaccharides. J Biol Chem 281: 5771-5779.
54. Paudel, H.K., and Li, W. (1999) Heparin-induced conformational change in microtubule-associated protein Tau as detected by chemical cross-linking and phosphopeptide mapping. J Biol Chem 274: 8029-8038.
55. Pyeon, D., Pearce, S.M., Lank, S.M., Ahlquist, P., and Lambert, P.F. (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5: e1000318.
56. Richards, R.M., Lowy, D.R., Schiller, J.T., and Day, P.M. (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 103: 1522-1527.
57. Roberts, J.N., Buck, C.B., Thompson, C.D., Kines, R., Bernardo, M., Choyke, P.L., etal. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13: 857-861.
58. Safaiyan, F., Kolset, S.O., Prydz, K., Gottfridsson, E., Lindahl, U., and Salmivirta, M. (1999) Selective effects of sodium chlorate treatment on the sulfation of heparan sulfate. J Biol Chem 274: 36267-36273.
59. Schelhaas, M. (2010) Come in and take your coat off - how host cells provide endocytosis for virus entry. Cell Microbiol 12: 1378-1388.
60. Schelhaas, M., Ewers, H., Rajamaki, M.L., Day, P.M., Schiller, J.T., and Helenius, A. (2008) Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog 4: e1000148.
61. Schelhaas, M., Shah, B., Holzer, M., Blattmann, P., Kuhling, L., Day, P.M., etal. (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raft-independent endocytosis. PLoS Pathog 8: e1002657.
62. Schowalter, R.M., Pastrana, D.V., and Buck, C.B. (2011) Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog 7: e1002161.
63. Selinka, H.C., Giroglou, T., Nowak, T., Christensen, N.D., and Sapp, M. (2003) Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol 77: 12961-12967.
64. Selinka, H.C., Florin, L., Patel, H.D., Freitag, K., Schmidtke, M., Makarov, V.A., and Sapp, M. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81: 10970-10980.
65. Shafti-Keramat, S., Handisurya, A., Kriehuber, E., Meneguzzi, G., Slupetzky, K., and Kirnbauer, R. (2003) Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 77: 13125-13135.
66. Stoll, M.S., and Feizi, T. (2010) Software tools for storing, processing and displaying carbohydrate microarray. In Glyco-Bioinformatics: Bits 'n' Bytes of Sugars. Hicks, M.G., and Kettner, C. (eds). Potsdam, Germany: Proceedings of the Beilstein Symposium on Glyco-Bioinformatics, pp. 123-140.
67. Surviladze, Z., Dziduszko, A., and Ozbun, M.A. (2012) Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 8: e1002519.
68. Tumova, S., Woods, A., and Couchman, J.R. (2000) Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J Biol Chem 275: 9410-9417.
69. Wittrup, A., Zhang, S.H., ten Dam, G.B., van Kuppevelt, T.H., Bengtson, P., Johansson, M., etal. (2009) ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican. J Biol Chem 284: 32959-32967.
70. Woodham, A.W., Da Silva, D.M., Skeate, J.G., Raff, A.B., Ambroso, M.R., Brand, H.E., etal. (2012) The S100A10 subunit of the annexin A2 heterotetramer facilitates L2-mediated human papillomavirus infection. PLoS ONE 7: e43519.
71. WuDunn, D., and Spear, P.G. (1989) Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol 63: 52-58.
72. Yoon, C.S., Kim, K.D., Park, S.N., and Cheong, S.W. (2001) alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem Biophys Res Commun 283: 668-673.
73. Yuspa, S.H., Hawley-Nelson, P., Koehler, B., and Stanley, J.R. (1980) A survey of transformation markers in differentiating epidermal cell lines in culture. Cancer Res 40: 4694-4703.